Highlights
The geometry of the synthetic CT is comparable to the CT in the H&N region.
Synthetic CT in the H&N region provides similar absorbed dose calculation as the CT.
Absorbed dose calculations in the dental region could benefit from using synthetic CT.
PurposeMagnetic resonance imaging (MRI)‐only radiotherapy is performed without computed tomography (CT). A synthetic CT (sCT) is used for treatment planning. The aim of this study was to develop a clinically feasible quality assurance (QA) procedure for sCT using the kV‐cone beam CT (CBCT), in an MRI‐only workflow for prostate cancer patients.Material and methodThree criteria were addressed; stability in Hounsfield Units (HUs), deviations in HUs between the CT and CBCT, and validation of the QA procedure. For the two first criteria, weekly phantom measurements were performed. For the third criteria, sCT, CT, and CBCT for ten patients were used. Treatment plans were created based on the sCT (MriPlannerTM). CT and CBCT images were registered to the sCT. The treatment plan was copied to the CT and CBCT and recalculated. Dose–volume histogram (DVH) metrics were used to evaluate dosimetric differences between the sCT plan and the recalculated CT and CBCT plans. HU distributions in sCT, CT, and CBCT were compared. Well‐defined errors were introduced in the sCT for one patient to evaluate efficacy of the QA procedure.ResultsThe kV‐CBCT system was stable in HU over time (standard deviation <40 HU). Variation in HUs between CT and CBCT was <60 HU. The differences between sCT–CT and sCT–CBCT dose distributions were below or equal to 1.0%. The highest mean dose difference for the CT and CBCT dose distribution was 0.6%. No statistically significant difference was found between total mean dose deviations from recalculated CT and CBCT plans, except for femoral head. Comparing HU distributions, the CBCT appeared to be similar to the CT. All introduced errors were identified by the proposed QA procedure, except all tissue compartments assigned as water.ConclusionThe results in this study shows that CBCT can be used as a clinically feasible QA procedure for MRI‐only radiotherapy of prostate cancer patients.
Purpose
The accuracy and precision of patient positioning is crucial in radiotherapy; however, there are no publications available using synthetic computed tomography (sCT) that evaluate rotations in head and neck (H&N) patients positioning or the effect of translation and rotation combined. The aim of this work was to evaluate the differences between using sCT with the CT for 2D‐ and 3D‐patient positioning in a magnetic resonance imaging (MRI)‐only workflow.
Methods
This study included 14 H&N cancer patients, with generated sCT data (MRI Planner v2.2) and the CT deformably registered to the MRI. Patient positioning was evaluated by comparing sCT against CT data: 3D cone beam CT (CBCT) was registered to the deformed CT (dCT) and sCT in six degrees of freedom (DoF) with a rigid auto‐registration algorithm and bone threshold, and 2D deformed digital reconstructed radiographs (dDRR) and synthetic DRRs (sDRR) were manually registered to orthogonal projections in five DoF by six blinded observers. The difference in displacement in all DoF were calculated for dCT and sCT, as well as for dDRR and sDRR. The interobserver variation was evaluated by separate application of the paired dDRR and sDRR registration matrices to the original coordinates of the planning target volume (PTV) structures and calculation of the Euclidean distance between the corresponding points. The Dice similarity coefficient (DSC) was calculated between dDRR/sDRR‐registered PTVs.
Results
The mean difference in patient positioning using CBCT was <0.7 mm and <0.3° and using orthogonal projections <0.4 mm and <0.2° in all directions. The maximum Euclidean distance was 5.1 mm, the corresponding mean (1SD) Euclidean distance and mean DSC were 3.5 ± 0.7 mm and 0.93, respectively.
Conclusions
This study shows that the sCT‐based patient positioning gives a comparable result with that based on CT images, allowing sCT to replace CT as reference for patient treatment positioning.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.